Researchers have developed an artificial intelligence-based model that can help pathologists grade certain lung cancer tumours and predict patients’ outcomes. It does this by assessing the growth ...

Offering genetic testing to patients with the blood cancer myeloma would help doctors spot those with the most aggressive forms of the disease so that their cancer can be targeted more effectively, ...

The Adult Drug Development Unit (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, comprises an internationally-leading group of >100 staff focused on early ...

Professor Paul Workman was 37 and already well established as a cancer researcher when his mother, Ena, died aged 68 from a rare bone tumour known as chordoma. About one in a million people are ...

Dr Gabriela Kramer-Marek’s group uses cutting-edge biomedical imaging techniques to gain information about the way particular genes drive cancer progression. Our group’s long-term goal is to develop ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...